Kv7-specific activators hyperpolarize resting membrane potential and modulate human iPSC-derived sensory neuron excitability
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Chronic pain is highly prevalent and remains a significant unmet global medical need. As part of a search for modulatory genes that confer pain resilience, we have studied two family cohorts where one individual reported much less pain than other family members that share the same pathogenic gain-of-function Nav1.7 mutation that confers hyperexcitability on pain-signaling dorsal root ganglion (DRG) neurons. In each of these kindreds, the pain-resilient individual carried a gain-of-function variant in Kv7.2 or Kv7.3, two potassium channels that stabilize membrane potential and reduce excitability. Our observation in this molecular genetic study that these gain-of-function Kv7.2 and 7.3 variants reduce DRG neuron excitability suggests that agents that activate or open Kv7 channels should attenuate sensory neuron firing. In the present study, we assess the effects on sensory neuron excitability of three Kv7 modulators—retigabine (Kv7.2 thru Kv7.5 activator), ICA-110381 (Kv7.2/Kv7.3 specific activator), and as a comparator ML277 (Kv7.1 specific activator)—in a “human-pain-in-a-dish” model (human iPSC-derived sensory neurons, iPSC-SN). Multi-electrode-array (MEA) recordings demonstrated inhibition of firing with retigabine and ICA-110381 (but not with ML277), with the concentration-response curve indicating that retigabine can achieve a 50% reduction of firing with sub-micromolar concentrations. Current-clamp recording demonstrated that retigabine hyperpolarized iPSC-SN resting potential and increased threshold. This study implicates Kv7.2/Kv7.3 channels as effective modulators of sensory neuron excitability, and suggest that compounds that specifically target Kv7.2/Kv7.3 currents in sensory neurons, including human sensory neurons, might provide an effective approach toward pain relief.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Within prefrontal and limbic circuits, Kv7 activity normalizes neuronal gain and suppresses stress-evoked firing escalation that impairs working memory and mood regulation [241,250,251].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [241]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KCNQ2 and KCNQ3 Potassium Channel Subunits: Molecular Correlates of the M-Channel
Wang, H. (1998) · Science · doi:10.1126/science.282.5395.1890 · Cited by 1,294 · cited 1×
“3 channel subunits co-assemble to form a heteromeric channel responsible for producing potassium M-current conductance that regulates subthreshold excitability of sensory neurons (Wang et al., 1998; Brown and Passmore, 2009).”
BackgroundKrebs, E. E., Gravely, A., Nugent, S., Jensen, A. C., DeRonne, B., Goldsmith, E. S., Kroenke, K., Bair, M. J., & Noorbaloochi, S. (2018) · JAMA · doi:10.1001/jama.2018.0899 · Cited by 983 · cited 1×
“In a long (12 months) randomized clinical trial in veterans with chronic pain, opioids were not better than non-steroidal anti-inflammatory drugs (Krebs et al., 2018).”
BackgroundBrown, D. A., & Passmore, G. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00111.x · Cited by 676 · cited 2×
“3 channel subunits co-assemble to form a heteromeric channel responsible for producing potassium M-current conductance that regulates subthreshold excitability of sensory neurons (Wang et al., 1998; Brown and Passmore, 2009).”
BackgroundMethodChambers, S. M., Qi, Y., Mica, Y., Lee, G., Zhang, X.-J., Niu, L., Bilsland, J., Cao, L., Stevens, E., Whiting, P., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2249 · Cited by 602
Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons
Dib-Hajj, S. D., Rush, A. M., Cummins, T. R., Hisama, F. M., Novella, S., Tyrrell, L., Marshall, L., & Waxman, S. G. (2005) · Brain · doi:10.1093/brain/awh514 · Cited by 490
Self-citationHumphreys, K., Shover, C. L., Andrews, C. M., Bohnert, A. S. B., Brandeau, M. L., Caulkins, J. P., Chen, J. H., Cuéllar, M.-F., Hurd, Y. L., Juurlink, D. N., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02252-2 · Cited by 421 · cited 1×
“The wide use of opioids has been followed by an epidemic of misuse and addiction in the United States and other countries (Humphreys et al., 2022).”
BackgroundTatulian, L., Delmas, P., Abogadie, F. C., & Brown, D. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05535.2001 · Cited by 406 · cited 3×
“, 2012) and the mechanism of action was reported to be a compound-induced leftward shift of the voltagedependence of activation resulting in both channels that are easier to open in response to membrane depolarizations as well as increased basal activity since the shifted activation voltage-dependence results in an in…”
BackgroundKCNQ/M Currents in Sensory Neurons: Significance for Pain Therapy
Passmore, G. M., Selyanko, A. A., Mistry, M., Al-Qatari, M., Marsh, S. J., Matthews, E. A., Dickenson, A. H., Brown, T. A., Burbidge, S. A., Main, M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07227.2003 · Cited by 366 · cited 1×
“1 channels (Passmore et al., 2003; Brown and Passmore, 2009; Barrese et al., 2018) and that our patient-derived iPSC-SN represent a good model system for in vitro studies (Alsaloum et al.”
MethodGunthorpe, M. J., Large, C. H., & Sankar, R. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03365.x · Cited by 319 · cited 1×
“The target for these effects of retigabine were determined to be the Kv7 family of voltage-gated potassium channels (Tatulian et al., 2001; Gunthorpe et al., 2012) and the mechanism of action was reported to be a compound-induced leftward shift of the voltagedependence of activation resulting in both channels that are…”
BackgroundSevere pain in veterans: the effect of age and sex, and comparisons with the general population
Nahin, R. L. (2017) · The Journal of Pain · doi:10.1016/j.jpain.2016.10.021 · Cited by 293 · cited 1×
“Chronic pain is highly prevalent and remains a significant unmet global medical need because current treatments are not effective (Nahin, 2017).”
BackgroundSingle-cell RNAseq reveals seven classes of colonic sensory neuron
Hockley, J. R. F., Taylor, T. S., Callejo, G., Wilbrey, A. L., Gutteridge, A., Bach, K., Winchester, W. J., Bulmer, D. C., McMurray, G., & Smith, E. S. J. (2019) · Gut · doi:10.1136/gutjnl-2017-315631 · Cited by 256
Status of peripheral sodium channel blockers for non-addictive pain treatment
Alsaloum, M., Higerd, G. P., Effraim, P. R., & Waxman, S. G. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-00415-2 · Cited by 177 · cited 1×
“Existing analgesics including currently available sodium channel blockers are sometimes effective, but their therapeutic utility is limited due to tolerability issues and off-target side effects (Alsaloum et al., 2020).”
BackgroundSelf-citationMolecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs
Miceli, F., Soldovieri, M. V., Martire, M., & Taglialatela, M. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.10.003 · Cited by 176 · cited 1×
“alternate tissues very challenging (Miceli et al., 2008; Jepps et al., 2013; Barrese et al., 2018).”
Single-cell RNA-seq reveals distinct injury responses in different types of DRG sensory neurons
Hu, G., Huang, K., Hu, Y., Du, G., Xue, Z., Zhu, X., & Fan, G. (2016) · Scientific Reports · doi:10.1038/srep31851 · Cited by 156
Young, G. T., Gutteridge, A., Fox, H. D., Wilbrey, A. L., Cao, L., Cho, L. T., Brown, A. R., Benn, C. L., Kammonen, L. R., Friedman, J. H., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.86 · Cited by 148 · cited 1×
“Differentiation was initiated using a modified Chambers protocol with LSB and 3i inhibitors (Chambers et al., 2012; Young et al., 2014).”
MethodDu, X., Hao, H., Gigout, S., Huang, D., Yang, Y., Li, L., Wang, C., Sundt, D., Jaffe, D. B., Zhang, H., et al. (2014) · Pain · doi:10.1016/j.pain.2014.08.025 · Cited by 139 · cited 1×
“Prior studies that have assessed the effect of retigabine in pain models in many cases have assessed only a single dose or a small number of concentrations in the 1–10 μM range (Roza and Lopez-Garcia, 2008; Xu et al., 2010; Du et al., 2014; Hayashi et al., 2014; Abd-Elsayed et al., 2015; Li et al., 2019; Zhang et al.,…”
BackgroundKCNQ-Encoded Potassium Channels as Therapeutic Targets
Barrese, V., Stott, J. B., & Greenwood, I. A. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052912 · Cited by 137 · cited 2×
“alternate tissues very challenging (Miceli et al., 2008; Jepps et al., 2013; Barrese et al., 2018).”
MethodMis, M. A., Yang, Y., Tanaka, B. S., Gomis‐Pérez, C., Liu, S., Dib-Hajj, F. B., Adi, T., García-Milian, R., Schulman, B. R. M., Dib‐Hajj, S. D., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2433-18.2018 · Cited by 101 · cited 4×
“To establish a baseline, (Figure 1), we recorded spontaneous activity of iPSC-SN (clone 303) derived from a subject who did not have a pain syndrome, who did not carry any mutations in the ion channel genes known to be expressed in sensory neurons assessed by whole exome sequencing [clone 303, (Mis et al., 2019)] The…”
BackgroundMethodSelf-citationContribution of K v 7 Channels to Basal Coronary Flow and Active Response to Ischemia
Khanamiri, S., Soltysinska, E., Jepps, T. A., Bentzen, B. H., Chadha, P. S., Schmitt, N., Greenwood, I. A., & Olesen, S.-P. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01244 · Cited by 88 · cited 1×
“5, Retigabine will also impact tissues such as smooth muscle which could lead to hypotension or defects in lymphatic function (Jepps et al., 2013; Khanamiri et al., 2013) or skeletal muscle where retigabine is reported to modulate proliferation and differentiation (Iannotti et al.”
BackgroundIannotti, F. A., Panza, E., Barrese, V., Viggiano, D., Soldovieri, M. V., & Taglialatela, M. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162800 · Cited by 81 · cited 1×
“, 2013) or skeletal muscle where retigabine is reported to modulate proliferation and differentiation (Iannotti et al., 2010).”
BackgroundRetigabine, the specific KCNQ channel opener, blocks ectopic discharges in axotomized sensory fibres
Roza, C., & Lopez-Garcia, J. A. (2008) · Pain · doi:10.1016/j.pain.2008.01.031 · Cited by 75 · cited 1×
“Prior studies that have assessed the effect of retigabine in pain models in many cases have assessed only a single dose or a small number of concentrations in the 1–10 μM range (Roza and Lopez-Garcia, 2008; Xu et al., 2010; Du et al., 2014; Hayashi et al., 2014; Abd-Elsayed et al., 2015; Li et al., 2019; Zhang et al.,…”
BackgroundMattmann, M. E., Yu, H., Lin, Z., Xu, K., Huang, X., Long, S., Wu, M., McManus, O. B., Engers, D. W., Le, U., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.060 · Cited by 70
New antiepileptic medication linked to blue discoloration of the skin and eyes
Clark, S., Antell, A., & Kaufman, K. (2015) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614560736 · Cited by 66 · cited 1×
“The use of retigabine, however, has been restricted due to significant side-effects (Faulkner and Burke, 2013; Clark et al., 2015), including the appearance of blue discoloration in tissues, especially the skin and the eyes.”
BackgroundXu, W., Wu, Y., Bi, Y., Tan, L., Gan, Y., & Wang, K. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-49 · Cited by 59
Abd-Elsayed, A. A., Ikeda, R., Jia, Z., Ling, J., Zuo, X., Li, M., & Gu, J. G. (2015) · Molecular Pain · doi:10.1186/s12990-015-0048-8 · Cited by 59 · cited 1×
“Prior studies that have assessed the effect of retigabine in pain models in many cases have assessed only a single dose or a small number of concentrations in the 1–10 μM range (Roza and Lopez-Garcia, 2008; Xu et al., 2010; Du et al., 2014; Hayashi et al., 2014; Abd-Elsayed et al., 2015; Li et al., 2019; Zhang et al.,…”
BackgroundRecent Developments on KCNQ Potassium Channel Openers
Wua, Y.-J., & Dworetzky, S. I. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363045 · Cited by 59 · cited 1×
“Chemically related compounds that maintain the effects of retigabine while avoiding some of these side effects are being developed (Wua and Dworetzky, 2005; Wu et al., 2013).”
BackgroundNegri, J. M., Menon, V., & Young‐Pearse, T. L. (2020) · eNeuro · doi:10.1523/eneuro.0080-19.2019 · Cited by 59 · cited 3×
“Subdividing of the wells into smaller groups of three or more wells that maintain similar means (Negri et al., 2020) facilitates testing of pharmacological compounds that could modulate neuronal firing.”
BackgroundMethodInfluentialActivation of Peripheral KCNQ Channels Attenuates Inflammatory Pain
Hayashi, H., Iwata, M., Tsuchimori, N., & Matsumoto, T. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-15 · Cited by 58 · cited 1×
“Prior studies that have assessed the effect of retigabine in pain models in many cases have assessed only a single dose or a small number of concentrations in the 1–10 μM range (Roza and Lopez-Garcia, 2008; Xu et al., 2010; Du et al., 2014; Hayashi et al., 2014; Abd-Elsayed et al., 2015; Li et al., 2019; Zhang et al.,…”
BackgroundJepps, T. A., Olesen, S., & Greenwood, I. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02133.x · Cited by 56 · cited 2×
“5, Retigabine will also impact tissues such as smooth muscle which could lead to hypotension or defects in lymphatic function (Jepps et al., 2013; Khanamiri et al., 2013) or skeletal muscle where retigabine is reported to modulate proliferation and differentiation (Iannotti et al.”
BackgroundSodium channels, the electrogenisome and the electrogenistat: lessons and questions from the clinic
Waxman, S. G. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.228460 · Cited by 53 · cited 1×
“The ability of an excitable cell to fire an action potential requires the coordinated expression and activity of multiple voltage-gated ion channels (Waxman, 2012).”
BackgroundSelf-citationStructural and electrophysiological basis for the modulation of KCNQ1 channel currents by ML277
Willegems, K., Eldstrom, J., Kyriakis, E., Ataei, F., Sahakyan, H., Dou, Y., Russo, S., Petegem, F. V., & Fedida, D. (2022) · Nature Communications · doi:10.1038/s41467-022-31526-7 · Cited by 51
Amato, G., Roeloffs, R., Rigdon, G. C., Antonio, B., Mersch, T., McNaughton-Smith, G., Wickenden, A. D., Fritch, P., & Suto, M. J. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200053x · Cited by 48 · cited 1×
“3 subunits (Amato et al., 2011), and ML277, which in contrast, is reported to be specific for Kv7.”
BackgroundRetigabine/Ezogabine, a KCNQ/KV7 channel opener: pharmacological and clinical data
Orhan, G., Wuttke, T. V., Nies, A. T., Schwab, M. G., & Lerche, H. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.706278 · Cited by 48 · cited 2×
“5 complexes (Orhan et al., 2012; Ostacolo et al., 2020), ICA-069673 (Provence et al.”
BackgroundZhang, F., Mi, Y., Qi, J., Li, J., Si, M., Guan, B., Du, X., An, H., & Zhang, H. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02232.x · Cited by 44 · cited 2×
“5 complexes (Orhan et al., 2012; Ostacolo et al., 2020), ICA-069673 (Provence et al., 2015; Wang et al., 2018) and QO58 (Zhang et al., 2013; Teng et al., 2016) are highly selective for Kv7.”
BackgroundOstacolo, C., Miceli, F., Di Sarno, V., Nappi, P., Iraci, N., Soldovieri, M. V., Ciaglia, T., Ambrosino, P., Vestuto, V., Lauritano, A., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00796 · Cited by 39 · cited 1×
“5 complexes (Orhan et al., 2012; Ostacolo et al., 2020), ICA-069673 (Provence et al.”
KCNQ variants and pain modulation: a missense variant in Kv7.3 contributes to pain resilience
Yuan, J., Estación, M., Mis, M. A., Tanaka, B. S., Schulman, B. R. M., Chen, L., Liu, S., Dib-Hajj, F. B., Dib‐Hajj, S. D., & Waxman, S. G. (2021) · Brain Communications · doi:10.1093/braincomms/fcab212 · Cited by 38
Self-citationTeng, B.-C., Song, Y., Zhang, F., Ma, T.-Y., Qi, J.-L., Zhang, H.-L., Li, G., & Wang, K. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.33 · Cited by 36 · cited 2×
“5 complexes (Orhan et al., 2012; Ostacolo et al., 2020), ICA-069673 (Provence et al., 2015; Wang et al., 2018) and QO58 (Zhang et al., 2013; Teng et al., 2016) are highly selective for Kv7.”
BackgroundNeuronal oscillator robustness to multiple global perturbations
Ratliff, J., Franci, A., Marder, E., & O’Leary, T. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.01.038 · Cited by 32 · cited 1×
“Numerous kinds of voltage-gated sodium and potassium channels, each with its own voltage ranges of gating and varying kinetics of voltage response, lead to profoundly nonlinear behavior of cellular excitability which makes determining the impact of modulating subsets of these ion channels with pharmacological agents c…”
BackgroundLi, L., Li, J., Zuo, Y., Dang, D., Frost, J. A., & Yang, Q. (2019) · The Journal of Pain · doi:10.1016/j.jpain.2018.11.001 · Cited by 31 · cited 1×
“Prior studies that have assessed the effect of retigabine in pain models in many cases have assessed only a single dose or a small number of concentrations in the 1–10 μM range (Roza and Lopez-Garcia, 2008; Xu et al., 2010; Du et al., 2014; Hayashi et al., 2014; Abd-Elsayed et al., 2015; Li et al., 2019; Zhang et al.,…”
BackgroundiPSCs and DRGs: stepping stones to new pain therapies
Alsaloum, M., & Waxman, S. G. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.11.005 · Cited by 30 · cited 2×
“, 2018) and that our patient-derived iPSC-SN represent a good model system for in vitro studies (Alsaloum et al., 2022; Alsaloum and Waxman, 2022).”
BackgroundSelf-citationFaulkner, M. A., & Burke, R. A. (2013) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.823399 · Cited by 28 · cited 1×
“The use of retigabine, however, has been restricted due to significant side-effects (Faulkner and Burke, 2013; Clark et al., 2015), including the appearance of blue discoloration in tissues, especially the skin and the eyes.”
BackgroundStable Control of Firing Rate Mean and Variance by Dual Homeostatic Mechanisms
Cannon, J., & Miller, P. (2017) · The Journal of Mathematical Neuroscience · doi:10.1186/s13408-017-0043-7 · Cited by 27 · cited 1×
“Numerous kinds of voltage-gated sodium and potassium channels, each with its own voltage ranges of gating and varying kinetics of voltage response, lead to profoundly nonlinear behavior of cellular excitability which makes determining the impact of modulating subsets of these ion channels with pharmacological agents c…”
BackgroundPore- and voltage sensor–targeted KCNQ openers have distinct state-dependent actions
Wang, C. K., Lamothe, S. M., Wang, A. W. T., Yang, R. Y., & Kurata, H. T. (2018) · The Journal of General Physiology · doi:10.1085/jgp.201812070 · Cited by 20 · cited 3×
“, 2012) and the mechanism of action was reported to be a compound-induced leftward shift of the voltagedependence of activation resulting in both channels that are easier to open in response to membrane depolarizations as well as increased basal activity since the shifted activation voltage-dependence results in an in…”
BackgroundProvence, A., Malysz, J., & Petkov, G. V. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225268 · Cited by 19
Antinociceptive Efficacy of Retigabine and Flupirtine for Gout Arthritis Pain
Zhang, F., Liu, S., Jin, L., Tang, L., Zhao, X., Yang, T., Wang, Y., Huo, B., Liu, R., & Li, H. (2020) · Pharmacology · doi:10.1159/000505934 · Cited by 19
Self-citationStem cell-derived sensory neurons modelling inherited erythromelalgia: normalization of excitability
Alsaloum, M., Labau, J. I. R., Liu, S., Effraim, P. R., & Waxman, S. G. (2022) · Brain · doi:10.1093/brain/awac031 · Cited by 18
Self-citationWu, Y., Conway, C. M., Sun, L., Machet, F., Chen, J., Chen, P., He, H., Bourin, C., Calandra, V., Polino, J. L., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.092 · Cited by 12 · cited 1×
“Chemically related compounds that maintain the effects of retigabine while avoiding some of these side effects are being developed (Wua and Dworetzky, 2005; Wu et al., 2013).”
BackgroundHow does gabapentin relieve neuropathic pain?
Devor, M. G. (2009) · Pain · doi:10.1016/j.pain.2009.05.027 · Cited by 8 · cited 1×
“Spontaneous activity of sensory neurons is a key driver of neuropathic pain, independent of an external stimulus (Devor, 2009).”
Background
Cited by
Beyond the hype: a comprehensive exploration of CBD’s biological impacts and mechanisms of action
Swenson, K. S. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00274-y · Cited by 23
“This outward flux of potassium pushes the membrane voltage back to baseline, and later to hyperpolarization (Estacion et al. 2023).”
InfluentialTargeting sodium channels — challenges for acute pain and the leap to chronic pain
Alsaloum, M., Vasylyev, D. V., & Waxman, S. G. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01127-1 · Cited by 15
“Agents such as retigabine that enhance the activity of these channels can reduce hyperactivity of iPSC-derived sensory neurons from people with inherited erythromelalgia 119 .”
Self-citationCarotenuto, L., Keminer, O., Carleo, G., Zaliani, A., Leo, A., Citraro, R., De Sarro, G., Dirkx, N., Kaji, M., Weckhuysen, S., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70119 · Cited by 10
“A similar IC 50 (1.7 μ M) was reported for retigabine in reducing spontaneous spiking activity in hiPSC-derived sensory neurons (Estacion et al., 2023).”
InfluentialZhang, B., Shi, X., Liu, X., Liu, Y., Li, X., Wang, Q., Huang, D., Zhao, W., Cui, J., Cao, Y., et al. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.101132 · Cited by 10
Jones, D. T., Zurek, N. A., & Alles, S. R. A. (2026) · Journal of Neuroscience · doi:10.1523/jneurosci.0926-25.2025 · Cited by 8
Metadata
- Authors
- Estacion, M., Liu, S., Cheng, X., Dib-Hajj, S., & Waxman, S. G.
- Affiliations
- Yale University (US)
- Corresponding author
- Waxman, Stephen G.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2023-02-27
- Volume
- 14
- Pages
- 1138556-1138556
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC10008904
- OpenAlex
- W4322506649
- Cited by
- 11
- References
- 48
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 1
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Veterans Affairs
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- Kv7.2, Kv7.3, Kv7 channels, retigabine, sensory neuron excitability, dorsal root ganglion neurons, resting membrane potential, hyperpolarization, chronic pain, pain resilience, potassium channel modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.